ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,676Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 309

$436K Total Retail Price of All Prescriptions

Rank: 26 out of 309

704 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,547 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 397 176 S3 1 1
SIMVASTATIN 242 180 2 5
LEVOTHYROXINE SODIUM 226 186 3 3
TRAMADOL HCL 189 97 4 15
OMEPRAZOLE 187 138 5 4
LISINOPRIL 178 139 6 2
FUROSEMIDE 146 116 7 7
LOSARTAN POTASSIUM 145 129 8 25
GABAPENTIN 143 86 9 8
AMLODIPINE BESYLATE 141 133 10 6
METFORMIN HCL 129 104 11 9
HYDROCHLOROTHIAZIDE 122 99 12 10
METOPROLOL SUCCINATE 112 106 13 14
ZOLPIDEM TARTRATE 112 98 13 18
MELOXICAM 111 77 15 27
ATORVASTATIN CALCIUM 99 77 16 13
METOPROLOL TARTRATE 88 63 17 11
TAMSULOSIN HCL 84 76 18 49
CARVEDILOL 81 65 19 17
CEPHALEXIN 81 69 19 84
AZITHROMYCIN 76 59 21 39
CYCLOBENZAPRINE HCL 74 36 R 22 31
FENTANYL 74 74 S2 22 20
NEXIUM 73 33 24 33
ESCITALOPRAM OXALATE 72 50 25 58
FLUOXETINE HCL 71 25 26 36
ATENOLOL 70 66 27 23
WARFARIN SODIUM 65 43 28 24
DOXYCYCLINE HYCLATE 64 49 29 147
CYMBALTA 63 43 30 22
CIPROFLOXACIN HCL 63 54 30 79
ALENDRONATE SODIUM 62 35 32 68
SPIRONOLACTONE 60 37 33 90
CITALOPRAM HBR 58 52 34 16
AMITRIPTYLINE HCL 57 54 R 35 55
RANITIDINE HCL 57 31 35 37
POTASSIUM CHLORIDE 55 49 37 21
CRESTOR 54 48 38 26
PANTOPRAZOLE SODIUM 54 40 38 78
PROAIR HFA 54 41 38 29
DIOVAN HCT 53 26 41 182
FLUTICASONE PROPIONATE 52 21 42 102
PRAVASTATIN SODIUM 50 50 43 12
PREDNISONE 50 37 43 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.